<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.sciencedaily.com/~d/styles/itemcontent.css"?><rss xmlns:media="http://search.yahoo.com/mrss/" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
	<channel>
		<title>Infectious Diseases News -- ScienceDaily</title>
		<link>https://www.sciencedaily.com/news/health_medicine/infectious_diseases/</link>
		<description>Read the latest medical research on the prevention, management, and treatment of infectious diseases. Read articles on HINI, influenza, C. difficile, HIV and AIDS, hepatitis, herpes, STDs and more.</description>
		<language>en-us</language>
		<pubDate>Sun, 06 Mar 2016 22:39:49 EST</pubDate>
		<lastBuildDate>Sun, 06 Mar 2016 22:39:49 EST</lastBuildDate>
		<ttl>60</ttl>
		<image>
			<title>Infectious Diseases News -- ScienceDaily</title>
			<url>https://www.sciencedaily.com/images/scidaily-logo-rss.png</url>
			<link>https://www.sciencedaily.com/news/health_medicine/infectious_diseases/</link>
			<description>For more science news, visit ScienceDaily.</description>
		</image>
		
		<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.sciencedaily.com/sciencedaily/health_medicine/infectious_diseases" /><feedburner:info uri="sciencedaily/health_medicine/infectious_diseases" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><feedburner:emailServiceId>sciencedaily/health_medicine/infectious_diseases</feedburner:emailServiceId><feedburner:feedburnerHostname>https://feedburner.google.com</feedburner:feedburnerHostname><item>
			<title>'Black death' offers clues to battling HIV, hepatitis C centuries later</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/3Jllpku8UEw/160304164913.htm</link>
			<description>The Black Death swept Europe in the 14th century eliminating up to half of the population but it left genetic clues that now may aid a researcher in treating HIV patients co-infected with hepatitis C using an anti-retroviral drug therapy. A new study will look at the blood samples of nearly 3,000 patients, primarily individuals with hemophilia, who were exposed to HIV during the early 1980s and late 1990s, to see if an inherited genetic variant that protects against HIV might also help prevent injury from Hepatitis C and other liver diseases.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/3Jllpku8UEw" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 04 Mar 2016 16:49:13 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/03/160304164913.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/03/160304164913.htm</feedburner:origLink></item>
		<item>
			<title>New placenta model could reveal how birth defect-causing infections cross from mom to baby</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/j9SBTtKP3LI/160304160354.htm</link>
			<description>Researchers have devised a cell-based model of the human placenta that could help explain how pathogens that cause birth defects cross from mother to unborn child.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/j9SBTtKP3LI" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 04 Mar 2016 16:03:54 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/03/160304160354.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/03/160304160354.htm</feedburner:origLink></item>
		<item>
			<title>Women need more of the HIV drug Truvada than men to prevent infection</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/82ulCNU9oV4/160304092014.htm</link>
			<description>Women need daily doses of the antiviral medication Truvada to prevent HIV infection while men only need two doses per week due to the way the drug accumulates in different body tissues, according to a new study from pharmacy researchers.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/82ulCNU9oV4" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 04 Mar 2016 09:20:14 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/03/160304092014.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/03/160304092014.htm</feedburner:origLink></item>
		<item>
			<title>Study offers clearest picture yet of how HIV defeats a cellular defender</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/xGwUl_qiWZw/160304091852.htm</link>
			<description>The first atomic-scale view of an interaction between the HIV capsid -- the protein coat that shepherds HIV into the nucleus of human cells -- and a host protein known as cyclophilin A has been illuminated by a recent study. This interaction is key to HIV infection, researchers say.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/xGwUl_qiWZw" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/03/160304091852.jpg" height="200" width="300" />
			<pubDate>Fri, 04 Mar 2016 09:18:52 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/03/160304091852.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/03/160304091852.htm</feedburner:origLink></item>
		<item>
			<title>New TSRI study shows HIV structure in unprecedented detail</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/IvPvNM9jtr0/160303145602.htm</link>
			<description>A new study from scientists at The Scripps Research Institute describes the high-resolution structure of the HIV protein responsible for recognition and infection of host cells. The studyis the first to show this HIV protein, known as the envelope trimer, in its natural or 'native' form.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/IvPvNM9jtr0" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/03/160303145602.jpg" height="253" width="300" />
			<pubDate>Thu, 03 Mar 2016 14:56:02 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/03/160303145602.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/03/160303145602.htm</feedburner:origLink></item>
		<item>
			<title>Researchers unravel pathways of potent antibodies that fight HIV infection</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/BVSq4_7wxT8/160303132947.htm</link>
			<description>One of the most crucial and elusive goals of an effective HIV vaccine is to stimulate antibodies that can attack the virus even as it relentlessly mutates. Now a research team has tracked rare potent antibodies in an HIV-infected individual and determined sequential structures that point to how they developed.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/BVSq4_7wxT8" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 03 Mar 2016 13:29:47 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/03/160303132947.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/03/160303132947.htm</feedburner:origLink></item>
		<item>
			<title>Novel small-molecule antiviral compound protects monkeys from deadly Ebola virus</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/oYrTS5YCSrI/160303120644.htm</link>
			<description>Rhesus monkeys were completely protected from Ebola virus when treated three days after infection with a compound that blocks the virus's ability to replicate. These encouraging preclinical results suggest the compound, known as GS-5734, should be further developed as a potential treatment, according to research findings.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/oYrTS5YCSrI" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/03/160303120644.jpg" height="200" width="300" />
			<pubDate>Thu, 03 Mar 2016 12:06:44 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/03/160303120644.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/03/160303120644.htm</feedburner:origLink></item>
		<item>
			<title>Why pharmaceutical firms may prefer to invest in drugs over vaccines</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/CcOOek1RTM4/160302204516.htm</link>
			<description>When it comes to addressing disease, many industry observers and public health advocates believe that pharmaceutical companies prefer to invest in drugs rather than vaccines, as preventives are perceived to be inherently less profitable. A new study on preventives versus treatments offers a new economic rationale for this trend -- the population risk for diseases resembles a Zipf distribution, where the demand curve for a drug is likely to support stronger revenue extraction from a drug than for a vaccine.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/CcOOek1RTM4" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 02 Mar 2016 20:45:16 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/03/160302204516.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/03/160302204516.htm</feedburner:origLink></item>
		<item>
			<title>Using graphene to fight bacteria</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/vMrBhxO6GAI/160302182234.htm</link>
			<description>Scientists are studying graphene oxide in the hopes of one day creating bacteria-killing catheters and medical devices. Coating surgical tools with this carbon-based compound could kill bacteria, reducing the need for antibiotics, decreasing the rates of post-operative infections and speeding recovery times.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/vMrBhxO6GAI" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 02 Mar 2016 18:22:34 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/03/160302182234.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/03/160302182234.htm</feedburner:origLink></item>
		<item>
			<title>Better way to treat abscesses: Add antibiotic to conventional approach</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/Tr9E2gOnezk/160302182231.htm</link>
			<description>A better way to treat many skin abscesses in the emergency department has been explained by researchers in a new article. The findings are important due to the emergence of community-acquired methicillin-resistant Staphylococcus aureus, or MRSA, which since 2000 has become the most common cause of skin infections in the U.S. The findings could improve recovery from infection while limiting its spread.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/Tr9E2gOnezk" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 02 Mar 2016 18:22:31 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/03/160302182231.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/03/160302182231.htm</feedburner:origLink></item>
		<item>
			<title>State laws boost flu vaccination rates in health care workers</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/IonZGik0qG8/160302121329.htm</link>
			<description>State laws mandating influenza immunization for people who work in health care increase their vaccination rates, according to new research. From 2000 to 2005, only Maine and New Hampshire had flu vaccine requirement laws for health care workers. During that period, the average flu vaccination rate for health care workers was 22.5 percent. From 2006 to 2011--when 19 other states, including Pennsylvania, passed similar laws--the average vaccination rate for health care workers increased to 50.9 percent.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/IonZGik0qG8" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 02 Mar 2016 12:13:29 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/03/160302121329.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/03/160302121329.htm</feedburner:origLink></item>
		<item>
			<title>Immunologists find new ways to beat 'bad guys'</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/hpexiATNBcQ/160302121327.htm</link>
			<description>One of the key components in a vaccine is an adjuvant, which serves to enhance our body's immune response to vaccination. Adjuvants have been around for almost a century however it is only recently that scientists are beginning to fully understand how they work.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/hpexiATNBcQ" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 02 Mar 2016 12:13:27 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/03/160302121327.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/03/160302121327.htm</feedburner:origLink></item>
		<item>
			<title>Zika virus medical countermeasures, challenges and opportunities</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/mtgo-SQuWd8/160301144753.htm</link>
			<description>The Zika virus epidemic was not anticipated, and the world was not prepared. At the beginning of January 2016, a volunteer assembly of industry experts, infectious disease outbreak specialists, academics and thought leaders was assembled to assess current knowledge and provide non-affiliated recommendations.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/mtgo-SQuWd8" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 01 Mar 2016 14:47:53 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/03/160301144753.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/03/160301144753.htm</feedburner:origLink></item>
		<item>
			<title>An Ebola virus-encoded microRNA-like fragment serves as a biomarker for early diagnosis</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/OX39GFXg7d0/160301114551.htm</link>
			<description>In a new study, scientists report that an Ebola virus-encoded microRNA-like fragment serves as a biomarker for early diagnosis. Ebola virus disease (EVD) is a severe infectious disease caused by Ebola virus species. EBOV caused an epidemic in West Africa in 2013-2015, and have resulted in at least 24,000 suspected cases and 10,000 confirmed deaths. Early diagnosis of EVD is not only essential for implementation of effective interventions but also critical for prevention of the spread of infection.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/OX39GFXg7d0" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 01 Mar 2016 11:45:51 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/03/160301114551.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/03/160301114551.htm</feedburner:origLink></item>
		<item>
			<title>Study calls into question current MERS vaccine strategy</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/UL0xAGLLOMU/160301114106.htm</link>
			<description>The Middle East Respiratory Syndrome coronavirus (MERS-CoV) develops mutations that make the virus less virulent during an outbreak rather than more virulent, researchers report. The study has implications for vaccine development.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/UL0xAGLLOMU" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 01 Mar 2016 11:41:06 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/03/160301114106.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/03/160301114106.htm</feedburner:origLink></item>
		<item>
			<title>Zika virus might cause Guillain-BarrÃ© syndrome, according to new evidence</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/_9HJcMMmSeM/160301075119.htm</link>
			<description>Analysis of blood samples from 42 patients diagnosed with Guillain-BarrÃ© syndrome (GBS) during the Zika virus outbreak in French Polynesia provides the first evidence that Zika virus might cause GBS, a severe neurological disorder, according to new research. Based on the analysis of data from French Polynesia, if 100,000 people were infected with Zika virus, 24 would develop GBS.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/_9HJcMMmSeM" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/03/160301075119.jpg" height="200" width="300" />
			<pubDate>Tue, 01 Mar 2016 07:51:19 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/03/160301075119.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/03/160301075119.htm</feedburner:origLink></item>
		<item>
			<title>Risk of catching Ebola from survivor 'very low', experts say</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/74hmxiQD4EY/160229152908.htm</link>
			<description>New research finds the risk of catching Ebola from a survivor to be 'very low.' Researchers set out to discover how long the Ebola virus persists in different human body fluids -- including blood, urine, semen, sweat, breast milk, feces, and vaginal fluids. While other health complications have been widely reported, the team did not find any evidence that the virus can reactivate to the point it becomes infectious for others by non-sexual contact.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/74hmxiQD4EY" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 29 Feb 2016 15:29:08 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160229152908.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160229152908.htm</feedburner:origLink></item>
		<item>
			<title>Capsule shedding: New bacterial pathway that promotes invasive disease</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/RSPODLmacec/160229095442.htm</link>
			<description>An enzyme antibiotics rely on to kill bacteria also promotes survival of pneumococcus and sets the stage for serious, invasive infections, scientists have discovered.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/RSPODLmacec" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/02/160229095442.jpg" height="200" width="300" />
			<pubDate>Mon, 29 Feb 2016 09:54:42 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160229095442.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160229095442.htm</feedburner:origLink></item>
		<item>
			<title>'Neoehrlichiosis' internationally diagnosed, successfully treated in patients without immunodeficiency for the first time</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/fH6ILsLBvOM/160229082120.htm</link>
			<description>The intercellular bacteria "Candidatus Neoehrlichia", as e.g. Borrelia, can be transferred by ticks. Approx. 4.2 % of indigenous ticks are infected with this rarely explored bacterium which, until today, has been exclusively identified as pathogenic bacterium in patients with an impairment of the immune system, such as in case of leukemia, rheumatism or after organ transplantation. Now, an interdisciplinary team of researchers has succeeded in diagnosing the bacterium in an otherwise healthy female patient with fever of an unknown origin - and treating it successfully.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/fH6ILsLBvOM" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 29 Feb 2016 08:21:20 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160229082120.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160229082120.htm</feedburner:origLink></item>
		<item>
			<title>Electron microscopy captures snapshot of structure coronaviruses use to enter cells</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/y_8zRo2zDDg/160226173209.htm</link>
			<description>A detailed analysis has been made, at the atomic level, of an infection mechanism of coronaviruses, the agents of both mild and deadly respiratory illness in people and animals. The model of the coronavirus spike protein, which promotes entry into cells, may inspire design of antibodies to block a variety of coronaviruses. It also offers clues about the animal species or cell types a coronavirus is primed to attack.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/y_8zRo2zDDg" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/02/160226173209.jpg" height="304" width="300" />
			<pubDate>Fri, 26 Feb 2016 17:32:09 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160226173209.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160226173209.htm</feedburner:origLink></item>
		<item>
			<title>Zika virus: Approaching the unknown</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/6r_aMLcq4mI/160226144140.htm</link>
			<description>Understanding the scale and range of neurological disease associated with Zika virus infection is an urgent priority, warn researchers.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/6r_aMLcq4mI" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 26 Feb 2016 14:41:40 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160226144140.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160226144140.htm</feedburner:origLink></item>
		<item>
			<title>HIV in Rhode Island: Newly diagnosed men often 'hooked up' online</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/KCBD97ERip8/160226144138.htm</link>
			<description>A strong correlation has been found between new HIV diagnoses among men who have sex with men in Rhode Island and their use of online hookup sites. Study authors have called for operators of hookup websites and apps to work with public health officials to include more prevention messaging.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/KCBD97ERip8" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/02/160226144138.jpg" height="215" width="300" />
			<pubDate>Fri, 26 Feb 2016 14:41:38 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160226144138.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160226144138.htm</feedburner:origLink></item>
		<item>
			<title>First in-human vaccine study for malaria caused by Plasmodium vivax</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/63RdS126sZ0/160226143949.htm</link>
			<description>Researchers recently published the results of testing a Plasmodium vivax malaria vaccine candidate in a human challenge model.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/63RdS126sZ0" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 26 Feb 2016 14:39:49 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160226143949.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160226143949.htm</feedburner:origLink></item>
		<item>
			<title>Structure of a hantavirus protein as a promising model for drug design</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/Jg6n34P_8qE/160226125321.htm</link>
			<description>There is no treatment for infection with the dangerous hantavirus. Scientists have now identified the three-dimensional structure of a hantavirus protein that is essential for replication of the virus. They have published their findings, providing a blueprint for the design of antiviral drugs.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/Jg6n34P_8qE" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/02/160226125321.jpg" height="117" width="300" />
			<pubDate>Fri, 26 Feb 2016 12:53:21 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160226125321.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160226125321.htm</feedburner:origLink></item>
		<item>
			<title>Antidepressant may improve cognitive symptoms in people with HIV</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/RlGHWd8akTI/160225153620.htm</link>
			<description>The antidepressant paroxetine modestly improves decision-making and reaction time, and suppresses inflammation in people with HIV-associated cognitive impairment, physicians report at the conclusion of a small, placebo-controlled clinical trial.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/RlGHWd8akTI" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 25 Feb 2016 15:36:20 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160225153620.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160225153620.htm</feedburner:origLink></item>
		<item>
			<title>Experimental Ebola antibody protects monkeys</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/9sUDsQtrGGk/160225153427.htm</link>
			<description>Scientists have discovered that a single monoclonal antibody isolated from a human Ebola virus disease survivor protected non-human primates when given as late as five days after lethal Ebola infection. The antibody can now advance to testing in humans as a potential treatment for Ebola virus disease. There are currently no licensed treatments for Ebola infection, which caused more than 11,000 deaths in the 2014-2015 outbreak in West Africa.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/9sUDsQtrGGk" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/02/160225153427.jpg" height="238" width="300" />
			<pubDate>Thu, 25 Feb 2016 15:34:27 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160225153427.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160225153427.htm</feedburner:origLink></item>
		<item>
			<title>Zika virus linked to stillbirth, other symptoms in Brazil</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/ILDyuAv5XJk/160225153403.htm</link>
			<description>In January, a pregnant Brazilian woman infected with the Zika virus had a stillborn baby who had signs of severe tissue swelling as well as central nervous system defects that caused near-complete loss of brain tissue. It is the first report to indicate a possible association of congenital Zika virus and damage to tissues outside the central nervous system, say researchers.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/ILDyuAv5XJk" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 25 Feb 2016 15:34:03 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160225153403.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160225153403.htm</feedburner:origLink></item>
		<item>
			<title>Immunotherapy agent can disrupt viral reservoir in SIV-infected monkeys</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/GT-daEyLjBQ/160225135716.htm</link>
			<description>An immune-enhancing treatment can push SIV out of its hideouts in infected monkeys that have the virus controlled with drugs, scientists report. Implications for the 'shock and kill' anti-HIV strategy.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/GT-daEyLjBQ" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 25 Feb 2016 13:57:16 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160225135716.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160225135716.htm</feedburner:origLink></item>
		<item>
			<title>Analyzing genetic tree sheds new light on disease outbreaks</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/4m5SLrWaCzM/160225134843.htm</link>
			<description>Scientists have a new tool for unraveling the mysteries of how diseases such as HIV move through a population, thanks to insights into phylogenetics, the creation of an organismâs genetic tree and evolutionary relationships.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/4m5SLrWaCzM" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/02/160225134843.jpg" height="201" width="300" />
			<pubDate>Thu, 25 Feb 2016 13:48:43 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160225134843.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160225134843.htm</feedburner:origLink></item>
		<item>
			<title>Most Ebola survivors examined in study experienced brain symptoms six months after infection</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/7iNKoj4dcY8/160224223425.htm</link>
			<description>Most of the 82 Ebola survivors in a new study from the world's largest Ebola outbreak had brain symptoms more than six months after the initial infection. The study is part of the larger Prevail III study, which follows patients with prior Ebola virus disease and their close contacts who serve as study controls.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/7iNKoj4dcY8" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 24 Feb 2016 22:34:25 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160224223425.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160224223425.htm</feedburner:origLink></item>
		<item>
			<title>Maraviroc-containing regimens safe, tolerable when taken for HIV prevention</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/vnpUKDGlTsM/160224151211.htm</link>
			<description>Maraviroc, an oral drug used to treat HIV infection, is safe and well-tolerated when taken daily as pre-exposure prophylaxis to prevent HIV infection by HIV-uninfected men who have sex with men at increased risk for acquiring HIV.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/vnpUKDGlTsM" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 24 Feb 2016 15:12:11 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160224151211.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160224151211.htm</feedburner:origLink></item>
		<item>
			<title>Rectal microbicide gel safe when used daily and with sex, international study finds</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/YFd4Cm6gULc/160224150854.htm</link>
			<description>A reduced glycerin formulation of tenofovir gel was found safe when used daily and around the time of sex, according to the first extended safety study of a rectal microbicide for HIV prevention from anal sex. The research also indicated that participants were as likely to follow through using the gel with sex as they were to using daily oral pre-exposure prophylaxis (PrEP).&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/YFd4Cm6gULc" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 24 Feb 2016 15:08:54 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160224150854.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160224150854.htm</feedburner:origLink></item>
		<item>
			<title>Zika epidemic highlights need for priority vaccine research for pregnant women</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/nHHz0UDo2Bg/160224150727.htm</link>
			<description>The recent outbreak of Zika virus disease and its link to fetal development highlights the need for pregnant women and those of reproductive age to be a priority group for developing and evaluating new vaccines and vaccine guidelines for Zika and other emerging infectious diseases.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/nHHz0UDo2Bg" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 24 Feb 2016 15:07:27 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160224150727.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160224150727.htm</feedburner:origLink></item>
		<item>
			<title>HIV preventative: Effect of PrEP on bone density is reversible</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/3RoLljBLJXE/160224100345.htm</link>
			<description>The slight loss in bone mineral density associated with HIV pre-exposure prophylaxis (PrEP) antiretroviral use is reversible in young adult patients who stop taking the drugs, according to new findings. PrEP is an HIV prevention strategy in which at-risk HIV-negative people take a daily pill of Truvada, which contains the antiretroviral drugs tenofovir and emtricitabine, to prevent them from becoming infected.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/3RoLljBLJXE" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 24 Feb 2016 10:03:45 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160224100345.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160224100345.htm</feedburner:origLink></item>
		<item>
			<title>Experimental Ebola vaccines well tolerated, immunogenic in phase 2 study</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/JosvWH8rXhY/160224100330.htm</link>
			<description>Two investigational vaccines designed to protect against Ebola virus disease were well-tolerated and induced an immune response among 1,000 vaccinated participants in the Phase 2 randomized, placebo-controlled clinical trial called PREVAIL I.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/JosvWH8rXhY" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 24 Feb 2016 10:03:30 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160224100330.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160224100330.htm</feedburner:origLink></item>
		<item>
			<title>Zolodrenic acid can prevent early bone loss in HIV patients on antiretroviral therapy</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/sFQIZPHPD3k/160223143157.htm</link>
			<description>A single dose of the drug zoledronic acid was found to inhibit the bone loss that is common in HIV-infected patients and that is increased during the first two years of treatment with antiretroviral therapy. Bone loss also leads to a higher rate of fracture in HIV-infected individuals.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/sFQIZPHPD3k" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 23 Feb 2016 14:31:57 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160223143157.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160223143157.htm</feedburner:origLink></item>
		<item>
			<title>Option B+ to prevent maternal transmission of HIV shows rise in women initiating therapy</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/5hhuqeb7HLk/160223143153.htm</link>
			<description>The first findings from a study in the Kingdom of Swaziland on a new approach to reduce mother to child transmission of HIV have been presented by researchers. These results show that implementation of Option B+ greatly increased the number of women initiating ART and dramatically improved ART coverage among pregnant women.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/5hhuqeb7HLk" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 23 Feb 2016 14:31:53 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160223143153.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160223143153.htm</feedburner:origLink></item>
		<item>
			<title>Influenza viruses can hide from the immune system</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/N_n5vE9VuvQ/160223102851.htm</link>
			<description>Influenza is able to mask itself, so that the virus is not initially detected by our immune system, a new study shows. The researchers behind the study hope that the discovery can be used to develop better treatment against influenza and chronic inflammation conditions such as rheumatoid arthritis.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/N_n5vE9VuvQ" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 23 Feb 2016 10:28:51 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160223102851.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160223102851.htm</feedburner:origLink></item>
		<item>
			<title>New virus transmission route discovered in pigs</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/gaRMedPwFAg/160223074841.htm</link>
			<description>Japanese Encephalitis (JE) virus causes serious inflammation of the brain in people and fertility problems in pigs. Mosquitoes were previously the only known transmission route. However, the virus can also be spread from pig to pig by direct contact, and this could enable it to circulate in pigs during the mosquito-free winter season.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/gaRMedPwFAg" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 23 Feb 2016 07:48:41 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160223074841.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160223074841.htm</feedburner:origLink></item>
		<item>
			<title>Recombinase Brec1 trend-setting for future HIV therapy</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/lM5IrZKJFvk/160222220838.htm</link>
			<description>Researchers have succeeded in developing a designer recombinase (Brec1) that is capable of specifically removing the provirus from infected cells of most primary HIV-1 isolates.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/lM5IrZKJFvk" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 22 Feb 2016 22:08:38 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160222220838.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160222220838.htm</feedburner:origLink></item>
		<item>
			<title>Dapivirine vaginal ring helped protect women against HIV in ASPIRE Phase III trial</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/9-Vh-7Czoss/160222155635.htm</link>
			<description>A vaginal ring containing an ARV called dapivirine that women use for a month at a time was safe and helped protect against HIV in a large-scale clinical trial of women in Africa. HIV risk was reduced significantly more among the study's older participants, who also used the ring most consistently. The results of the ASPIRE study, together with results of a second Phase III trial, are a boost to HIV prevention efforts in women.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/9-Vh-7Czoss" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 22 Feb 2016 15:56:35 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160222155635.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160222155635.htm</feedburner:origLink></item>
		<item>
			<title>Bat 'super immunity' could help protect people</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/Gdvp3h6-mYA/160222155631.htm</link>
			<description>For the first time, researchers have uncovered a unique ability in bats which allows them to carry but remain unaffected by lethal diseases.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/Gdvp3h6-mYA" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/02/160222155631.jpg" height="450" width="300" />
			<pubDate>Mon, 22 Feb 2016 15:56:31 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160222155631.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160222155631.htm</feedburner:origLink></item>
		<item>
			<title>One drug used to prevent HIV transmission during pregnancy shows evidence of developmental effects</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/ia6JLBXHiFE/160222142813.htm</link>
			<description>The antiretroviral drug atazanavir -- sometimes included in treatments to prevent mother-to-child HIV transmission during pregnancy -- may have small but significant effects on infant development, reports a new study.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/ia6JLBXHiFE" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 22 Feb 2016 14:28:13 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160222142813.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160222142813.htm</feedburner:origLink></item>
		<item>
			<title>Newly discovered HIV genome modification may put a twist on vaccine and drug design</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/iV1qfIrq89E/160222114928.htm</link>
			<description>HIV infection of human immune cells triggers a massive increase in methylation, a chemical modification, to both human and viral RNA, aiding replication of the virus. A new study identifies a new mechanism for controlling HIV replication and its interaction with the host immune system.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/iV1qfIrq89E" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 22 Feb 2016 11:49:28 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160222114928.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160222114928.htm</feedburner:origLink></item>
		<item>
			<title>The Charlie Sheen effect on HIV prevention</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/gH6satnDl3Q/160222114923.htm</link>
			<description>For some time scientists and advocates have recognized the importance of celebrity in public health. Could Sheen's disclosure, albeit tragic, generate renewed national attention for HIV and HIV prevention, providing an important public health benefit? A new study finds that Charlie Sheen's HIV disclosure corresponded with record levels of public engagement with HIV and HIV prevention.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/gH6satnDl3Q" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 22 Feb 2016 11:49:23 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160222114923.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160222114923.htm</feedburner:origLink></item>
		<item>
			<title>Parents rate flu vaccine less important, effective, safe than other childhood vaccines</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/ZqL3jZZjOKI/160222091535.htm</link>
			<description>Parents who do not get their children flu shots rate flu vaccine less favorably than other childhood vaccines, a national poll finds. Fifty-nine percent of parents whose child did not receive the flu vaccine this season say it is less important than other childhood vaccines -- compared to only 14 percent of parents whose child got a flu shot, according to a new report.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/ZqL3jZZjOKI" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/02/160222091535.jpg" height="207" width="300" />
			<pubDate>Mon, 22 Feb 2016 09:15:35 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160222091535.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160222091535.htm</feedburner:origLink></item>
		<item>
			<title>Blood test could transform tuberculosis diagnosis, treatment in developing countries</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/2UAAKv-bGEg/160219185210.htm</link>
			<description>A simple blood test that can accurately diagnose active tuberculosis could make it easier and cheaper to control a disease that kills 1.5 million people every year.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/2UAAKv-bGEg" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 19 Feb 2016 18:52:10 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160219185210.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160219185210.htm</feedburner:origLink></item>
		<item>
			<title>Researchers discover new Ebola-fighting antibodies in blood of outbreak survivor</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/hKMrPx6yB4c/160219141406.htm</link>
			<description>A new group of powerful antibodies to fight Ebola virus has been discovered by a team of scientists. The antibodies, isolated from the blood of a survivor of the 2014 Ebola outbreak and the largest panel reported to date, could guide the development of a vaccine or therapeutic against Ebola.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/hKMrPx6yB4c" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/02/160219141406.jpg" height="360" width="300" />
			<pubDate>Fri, 19 Feb 2016 14:14:06 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160219141406.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160219141406.htm</feedburner:origLink></item>
		<item>
			<title>B-cell diversity in immune system's germinal centers may hold key to broad-spectrum vaccines</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/DEqM7Xcm5Do/160218145137.htm</link>
			<description>The germinal centers that form in the body's lymph nodes work as a fitness boot camp in which B cells evolve to produce antibodies of increasingly higher affinity to an invading pathogen. This new finding overturns a previously held notion that only a narrow range of B cells can survive this training and go on to secrete high-affinity antibodies. This revised understanding may aid development of effective vaccines against HIV, influenza, and other viruses that mutate rapidly.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/DEqM7Xcm5Do" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 18 Feb 2016 14:51:37 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160218145137.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160218145137.htm</feedburner:origLink></item>
		<item>
			<title>What makes a bacterial species able to cause human disease?</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/jKKt47o3GM0/160218145135.htm</link>
			<description>The first comprehensive, cross-species genomic comparison of all 20 known species of &lt;em&gt;Leptospira&lt;/em&gt;, a bacterial genus that can cause disease and death in livestock and other domesticated mammals, wildlife and humans, has now been completed by scientists. The resulting analyses reveal novel adaptations and traits in infectious species of Leptospira that not only help illuminate its evolutionary history, but may also provide new preventive and treatment approaches.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/jKKt47o3GM0" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 18 Feb 2016 14:51:35 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160218145135.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160218145135.htm</feedburner:origLink></item>
		<item>
			<title>Scientists discover way to potentially track and stop human and agricultural viruses</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/Ht_y8ZtZyOo/160218133517.htm</link>
			<description>A new discovery has broad ranging applications in stopping viral outbreaks such as hepatitis C in humans and a number of viruses in plants and animals because it applies to many viruses in the largest category of viral classes -- positive-strand RNA viruses, report scientists.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/Ht_y8ZtZyOo" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/02/160218133517.jpg" height="200" width="300" />
			<pubDate>Thu, 18 Feb 2016 13:35:17 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160218133517.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160218133517.htm</feedburner:origLink></item>
		<item>
			<title>Zika virus can cross placental barrier, but link with microcephaly remains unclear, new evidence suggests</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/ffZcJ2v7lBc/160218060741.htm</link>
			<description>Zika virus has been detected in the amniotic fluid of two pregnant women whose fetuses had been diagnosed with microcephaly, according to a study. The report suggests that Zika virus can cross the placental barrier, but does not prove that the virus causes microcephaly, as more research is needed to understand the link.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/ffZcJ2v7lBc" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/02/160218060741.jpg" height="200" width="300" />
			<pubDate>Thu, 18 Feb 2016 06:07:41 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160218060741.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160218060741.htm</feedburner:origLink></item>
		<item>
			<title>Connection between anal cancer, HPV</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/FNSpi1uR50g/160217140425.htm</link>
			<description>The results of a study demonstrating a connection between anal cancer and human papillomavirus infection has been published by researchers. It builds on research that indicated an increased likelihood that the two diseases would coexist in some women.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/FNSpi1uR50g" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 17 Feb 2016 14:04:25 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160217140425.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160217140425.htm</feedburner:origLink></item>
		<item>
			<title>Protein structure illuminates how viruses take over cells</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/2zVndI4SEJ0/160217140313.htm</link>
			<description>Using cutting-edge imaging technology, researchers have determined the structure of a protein complex that lets viruses similar to the human immunodeficiency virus (HIV) establish permanent infections within their hosts.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/2zVndI4SEJ0" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/02/160217140313.jpg" height="237" width="300" />
			<pubDate>Wed, 17 Feb 2016 14:03:13 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160217140313.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160217140313.htm</feedburner:origLink></item>
		<item>
			<title>New research could help improve HIV/AIDS therapies</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/6GKGzarwCLE/160217140307.htm</link>
			<description>An experimental procedure that involves beaming X-rays at immobilized molecules resulted in a major step forward in exploring new therapies to combat HIV/AIDS and retrovirus-based cancers, report scientists.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/6GKGzarwCLE" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 17 Feb 2016 14:03:07 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160217140307.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160217140307.htm</feedburner:origLink></item>
		<item>
			<title>Scientists discover bird blood cell which destroys fatal fungal infection</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/59nTBlyvSKA/160217091332.htm</link>
			<description>Scientists reveal how birds can carry potentially fatal infections to humans but not get ill. They say that the white blood cell in birds blocks growth of fatal infection, adding that this discovery could help in preventing humans from contracting diseases including bird flu.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/59nTBlyvSKA" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/02/160217091332.jpg" height="192" width="300" />
			<pubDate>Wed, 17 Feb 2016 09:13:32 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160217091332.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160217091332.htm</feedburner:origLink></item>
		<item>
			<title>Tests to detect acute HIV infection</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/TcYaT79sHvM/160216123441.htm</link>
			<description>Researchers evaluated the performance of an HIV antigen/antibody (Ag/Ab) combination assay to detect acute HIV infection (early infection) compared with pooled HIV RNA testing, the reference standard.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/TcYaT79sHvM" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 16 Feb 2016 12:34:41 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160216123441.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160216123441.htm</feedburner:origLink></item>
		<item>
			<title>New anti-biofilm compounds show promise against drug-resistant bacteria linked to hospital infections</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/KSJUtJS5pv8/160216091145.htm</link>
			<description>A new class of anti-biofilm compounds derived from marine microorganisms has been discovered by researchers who report that these show promise against a drug-resistant bacterium commonly associated with hospital-acquired infections.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/KSJUtJS5pv8" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 16 Feb 2016 09:11:45 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160216091145.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160216091145.htm</feedburner:origLink></item>
		<item>
			<title>Immune response to flu vaccine linked to recipients' ethnic background</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/ag_X19xuIFM/160216090124.htm</link>
			<description>How well a flu shot protects you from the virus can depend on your ethnic background and other inherited factors, report scientists. Results suggest future "universal" vaccines could be tailored to individuals and populations.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/ag_X19xuIFM" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 16 Feb 2016 09:01:24 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160216090124.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160216090124.htm</feedburner:origLink></item>
		<item>
			<title>Threat of cytomegalovirus far outweighs Zika risk, researcher says</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/infectious_diseases/~3/RDmHEsgftEQ/160215143619.htm</link>
			<description>Researcher studies the impact of CMV on healthcare providers.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/infectious_diseases/~4/RDmHEsgftEQ" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 15 Feb 2016 14:36:19 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160215143619.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160215143619.htm</feedburner:origLink></item>
	</channel>
</rss><!-- Page successfully written to cache. --><!-- cached Sun, 06 Mar 2016 22:37:01 EST -->
